← Back to Patent Explorer
EP0177443A1 Expired / Lapsed EP ⏱️ 0.0 years remaining

Crystal modification of disodium-3-amino-1-hydroxy-propane-1,1-diphosphonate

Assignee: Novartis Ag henkel Auf Aktie KG
•
Filing: 1985-07-30
•
Granted: —
•
Expires: 2005-07-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Translated from German Die Erfindung betrifft eine neue, kristallwasserhaltige Kristallmodifikation des Dinatrium-3-amino-1-hydroxypropan-1,1-diphosponates der Formel <IMAGE> bzw. ein Verfahren zur Herstellung derselben. Diese ist zur oralen Behandlung von Störungen des Calcium- und Phosphatstoffwechsels und damit verbundener Erkrankungen von Warmblütern geeignet. The invention relates to a new crystal water-containing crystal modification of the disodium-3-amino-1-hydroxypropane-1,1-diphosponate of the formula <IMAGE> and a process for the production thereof. This is suitable for the oral treatment of disorders of calcium and phosphate metabolism and related diseases of warm-blooded animals.

Inventors

  • 👤 Peter Heinrich Dr. Stahl
  • 👤 Beat Dr. Schmitz

Bibliographic Details

Application Number —
Jurisdiction EP
Data Source google_patents
Last Synchronized 2026-11-08 14:57
CPC Classifications
C; C07; C07F; C07F9/00; C07F9/02; C07F9/06; C07F9/16; C07F9/165; C07F9/28; C07F9/38; C07F9/3804; C07F9/3839; C07F9/3873; A; A61; A61P; A61P3/00; A61P3/12; A61P3/14

Claims Analysis

Total Claims: 0
No claims parsed yet. Click Sync Now above to re-index claims from Google Patents.

References Cited (Backward Citations)

DE2405254A1 Cited
DE2553963A1 Cited
US4304734A Cited

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag